The subject matter disclosed herein relates generally to cancer therapy and to anti-cancer compounds and imaging agents. More specifically, the subject matter disclosed herein relates to agents that target MClR and their use in the treatment of cancer. Methods of screening for MClR tarĀgeted agents are also disclosed.Medical, Therapeutics